机构:[1]Department of Infectious Diseases,The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China[2]Department of Bioengineering and Therapeutic Sciences and Liver Center,University of California, San Francisco, California[3]Department of General Surgery,The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China[4]Department of Pediatrics,Zhongnan Hospital of Wuhan University, Wuhan, PR China[5]Hepatic Surgery Center,Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China华中科技大学同济医学院附属同济医院[6]Clinical Medical College of Yangzhou University,Yangzhou, PR China[7]Liver Transplantation Division,Department of Liver Surgery,West China Hospital, Sichuan University, Chengdu, PR China四川大学华西医院[8]Laboratory of Liver Surgery,West China Hospital, Sichuan University, Chengdu, PR China四川大学华西医院[9]Center for Drug Discovery,Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas[10]Institute of Pathology,University of Regensburg, Regensburg, Germany
Supported by NIH grants R01CA239251 (X.C.), R01DK121970 (F.L.),
and P30DK026743 (University of California, San Francisco, Liver Center);
National Natural Science Foundation of China grant 81902449 (M.X.); and
China Scholarship Council scholarship contract number 201806280217
(Y.Z.).
第一作者机构:[1]Department of Infectious Diseases,The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China[2]Department of Bioengineering and Therapeutic Sciences and Liver Center,University of California, San Francisco, California
共同第一作者:
通讯作者:
通讯机构:[1]Department of Infectious Diseases,The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China[3]Department of General Surgery,The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, PR China[*1]Department of Infectious Diseases, The First Affiliated Hospital of Xi’an Jiaotong University, No. 277 Yanta West Road, Xi’an, Shaanxi, PR China, 710061[*2]Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, 513 Parnassus Ave., S-816, San Francisco, CA 94143.
推荐引用方式(GB/T 7714):
Yi Zhou,Meng Xu,Pin Liu,et al.Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model[J].AMERICAN JOURNAL OF PATHOLOGY.2020,190(7):1414-1426.doi:10.1016/j.ajpath.2020.03.010.
APA:
Yi Zhou,Meng Xu,Pin Liu,Binyong Liang,Manning Qian...&Xin Chen.(2020).Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.AMERICAN JOURNAL OF PATHOLOGY,190,(7)
MLA:
Yi Zhou,et al."Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model".AMERICAN JOURNAL OF PATHOLOGY 190..7(2020):1414-1426